Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0012 | 1 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 9.5e-05 | 1 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 7.7e-05 | 1 |